英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
197305查看 197305 在百度字典中的解释百度英翻中〔查看〕
197305查看 197305 在Google字典中的解释Google英翻中〔查看〕
197305查看 197305 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Epratuzumab - Wikipedia
    Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE) [1][2]
  • Epratuzumab - an overview | ScienceDirect Topics
    Epratuzumab is an anti-CD22 monoclonal antibody that in vitro demonstrates a different and synergistic mechanism of inducing apoptosis in B-cell lymphomas (than does rituximab) (Fayad et al , 2007)
  • Epratuzumab - UCB
    European League Against Rheumatism (EULAR) 2011 May 25-28, 2011;London, UK
  • Epratuzumab - an overview | ScienceDirect Topics
    Epratuzumab is defined as a humanized monoclonal antibody that targets CD22 on B cells, initially developed for B-cell malignancies and currently evaluated for its efficacy in treating patients with systemic lupus erythematosus (SLE)
  • Efficacy and safety of epratuzumab in patients with moderate severe . . .
    Objective To identify a suitable dosing regimen of the CD22-targeted monoclonal antibody epratuzumab in adults with moderately to severely active systemic lupus erythematosus (SLE)
  • Definition of epratuzumab - NCI Dictionary of Cancer Terms
    Epratuzumab is a type of monoclonal antibody A substance being studied in the treatment of certain types of non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL) It is also being studied in the treatment of an autoimmune disease called systemic lupus erythematosus (SLE)
  • Efficacy and Safety of Epratuzumab in Moderately to Severely Active . . .
    Epratuzumab, a monoclonal antibody that targets CD22, modulates B cell signaling without substantial reductions in the number of B cells
  • Epratuzumab - PubChem
    Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2) This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus
  • Epratuzumab: Uses, Dosage, Side Effects, Food Interaction FAQ
    Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2) This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus
  • Epratuzumab: Uses, Interactions, Mechanism of Action | DrugBank
    Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2) This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus





中文字典-英文字典  2005-2009